Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.0K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

6.3K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unveiling dry eye disease prior to cataract surgery: A multicenter clinical study.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026
Same author

Results of adjunctive homogenate amniotic membrane eye drops in the management of refractory ocular surface disease with dry eye manifestations.

International ophthalmology·2026
Same author

A Multicenter, Real-World Experience with Polyhexamethylene Biguanide (PHMB) 0.08% Monotherapy for Treating Acanthamoeba Keratitis: A Retrospective Review of 39 Cases.

Ophthalmology and therapy·2026
Same author

GPT-5-assisted versus expert surgeon refractive planning in smooth incision lenticule keratomileusis (SILK): comparative analysis and visual outcomes.

International ophthalmology·2026
Same author

Inverted ILM Drape Technique for the Management of Refractory Full Thickness Macular Hole.

Retinal cases & brief reports·2026
Same author

Old clear penetrating keratoplasty with high astigmatism: conservative solution with customized foldable Toric Piggyback intraocular lens.

International ophthalmology·2026

Related Experiment Video

Updated: Nov 20, 2025

An Alkali-burn Injury Model of Corneal Neovascularization in the Mouse
10:52

An Alkali-burn Injury Model of Corneal Neovascularization in the Mouse

Published on: April 7, 2014

17.1K

Corneal angiogenic privilege and its failure.

Antonio Di Zazzo1, Daniele Gaudenzi1, Jia Yin2

  • 1Ophthalmology Operative Complex Unit, University Campus Bio-Medico, Rome, Italy.

Experimental Eye Research
|January 25, 2021
PubMed
Summary

The cornea stays avascular to maintain clear vision, a state called corneal angiogenic privilege. This balance between anti-angiogenic and pro-angiogenic factors prevents blood vessel growth, but injuries can disrupt this to cause corneal angiogenesis.

More Related Videos

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye
11:49

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye

Published on: August 16, 2014

17.2K
Author Spotlight: Decoding Corneal Neovascularization with Alkali Burn Model for Future Therapeutic Strategies
04:17

Author Spotlight: Decoding Corneal Neovascularization with Alkali Burn Model for Future Therapeutic Strategies

Published on: June 30, 2023

3.2K

Related Experiment Videos

Last Updated: Nov 20, 2025

An Alkali-burn Injury Model of Corneal Neovascularization in the Mouse
10:52

An Alkali-burn Injury Model of Corneal Neovascularization in the Mouse

Published on: April 7, 2014

17.1K
The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye
11:49

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye

Published on: August 16, 2014

17.2K
Author Spotlight: Decoding Corneal Neovascularization with Alkali Burn Model for Future Therapeutic Strategies
04:17

Author Spotlight: Decoding Corneal Neovascularization with Alkali Burn Model for Future Therapeutic Strategies

Published on: June 30, 2023

3.2K

Area of Science:

  • Ophthalmology
  • Vascular Biology
  • Corneal Science

Background:

  • The cornea maintains an avascular state crucial for optical clarity.
  • This avascularity, termed corneal angiogenic privilege, relies on a delicate balance of pro- and anti-angiogenic factors.
  • Disruption of this balance can lead to pathological corneal neovascularization.

Purpose of the Study:

  • To review the mechanisms maintaining corneal avascularity.
  • To explore the mediators involved in corneal angiogenic privilege.
  • To understand the process of corneal angiogenesis following injury.

Main Methods:

  • Literature review of studies on corneal angiogenesis and avascularity.
  • Analysis of molecular and cellular mechanisms regulating blood vessel formation in the cornea.
  • Examination of the transition from avascular to vascular states in the cornea.

Main Results:

  • Corneal angiogenic privilege is maintained by a complex interplay of multiple signaling pathways.
  • Specific anti-angiogenic factors dominate in the resting cornea.
  • Various injuries can trigger pro-angiogenic responses, overriding the privilege and leading to neovascularization.

Conclusions:

  • The cornea's avascular state is actively regulated by a dynamic equilibrium of mediators.
  • Understanding this balance is key to developing therapies for corneal diseases involving neovascularization.
  • Corneal angiogenesis is a complex response to injury, involving the breakdown of normally protective mechanisms.